All News

2067 articles, sorted by publication time.

Clinical Medicine · us

Head-to-Head Comparison of Treatments for Multiple Food Allergies: Omalizumab Comes Out Ahead, but the Key Is Not Just the Amount Tolerated

A U.S. randomized trial found that participants who continued the anti-IgE antibody were more likely to pass high-dose challenges with three foods; however, the difference was driven mainly by more adverse reactions and withdrawals with oral immunotherapy, rather than a large disparity in efficacy among those who completed treatment.

Medical Technology · us

Could Precancerous Cells Be Cleared Without Removing the Bladder? U.S. Team Uses an Electrical Pulse Device to Prevent Bladder Cancer Recurrence

Researchers are adapting irreversible electroporation into a flexible catheter in an attempt to remove diseased cells from the bladder’s innermost layer and allow healthy tissue to regenerate. The NIH-supported project remains in preclinical development and will first use bladder-on-a-chip models built from patient cells to test safety and effectiveness.

Biotechnology and Pharmaceuticals · us

Phase 3 Trial Misses Prespecified Threshold, but Seralutinib Will Still Seek FDA Review in September

The FDA considers the statistical evidence and magnitude of efficacy to be substantive review issues rather than procedural barriers to filing; Gossamer Bio has also regained worldwide rights, but whether the application is accepted for review and ultimately approved will still depend on an evaluation of the totality of the evidence.